Page last updated: 2024-09-02

senktide and mozavaptan

senktide has been researched along with mozavaptan in 1 studies

Compound Research Comparison

Studies
(senktide)
Trials
(senktide)
Recent Studies (post-2010)
(senktide)
Studies
(mozavaptan)
Trials
(mozavaptan)
Recent Studies (post-2010) (mozavaptan)
292150165824

Protein Interaction Comparison

ProteinTaxonomysenktide (IC50)mozavaptan (IC50)
Vasopressin V2 receptorHomo sapiens (human)0.6373
Vasopressin V1a receptorRattus norvegicus (Norway rat)3.2
Vasopressin V1a receptorHomo sapiens (human)1.1373
Vasopressin V1b receptorHomo sapiens (human)2
Vasopressin V1b receptorRattus norvegicus (Norway rat)5
Vasopressin V2 receptor Rattus norvegicus (Norway rat)0.012

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamiya, H; Matsumoto, T; Nakayama, Y; Saigo, A; Saito, R; Takano, Y; Tran, M; Yamada, K1

Other Studies

1 other study(ies) available for senktide and mozavaptan

ArticleYear
Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
    Neuroscience letters, 1993, Sep-03, Volume: 159, Issue:1-2

    Topics: Animals; Arginine Vasopressin; Benzazepines; Diuresis; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Urodynamics; Water

1993